Observational Study of Adults and Adolescents With Erythropoietic Protoporphyria (EPP) and X-linked Porphyria (XLP)
The purpose of this study is to collect information about the effects of EPP/XLP in
adults and adolescents. This is an observational study in which participants will not
receive any treatment. Study details include:
- The study duration will be up to 6 months for ...
Age: 12 years - 66+
Gender: All
HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLP
This is an open-label, long-term extension study to investigate the safety, tolerability
and efficacy of DISC-1459 in participants with EPP.
Age: 12 years - 66+
Gender: All
Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and PPIX Concentrations in Participants With EPP
This is a Phase 2, multi-center, double-blind, placebo-controlled, parallel group study of
bitopertin to evaluate the safety, tolerability, efficacy, and PPIX concentration change in
participants with EPP. Participants may roll over to an open label extension portio...
Age: 18 years - 66+
Gender: All
Longitudinal Study of the Porphyrias
The objective of this protocol is to conduct a longitudinal multidisciplinary
investigation of the human porphyrias including the natural history, morbidity, pregnancy
outcomes, and mortality in people with these disorders.
Age: 1 minute - 66+
Gender: All